Cite Filings / PHAT / 0000950170-23-012698

Feed Companies Filings Check

Sign in

ARS

Annual Report to Security Holders

Phathom Pharmaceuticals, Inc. Filed 2023-04-13 Acc 0000950170-23-012698

Documents 1

ARS Annual Report to Security Holders , 2022_phathom_ars.pdf

Around this filing

2024-04-12 ARS Annual Report to Security Holders
2023-04-13 DEFA14A Proxy Materials
2023-04-13 DEF 14A Proxy Statement
2023-04-13 ARS Annual Report to Security Holders
2023-04-11 4 Director bought 1,000 shares at $7.55 ($7,550)
2023-04-11 4 Chief Operating Officer bought 10,000 shares at $8.26 ($82,600)
2023-04-07 4 President and Chief Executive bought 12,919 shares at $7.82 ($101,025)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading 2022_phathom_ars.pdf…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…